HIGHLIGHTS
- who: Tuo Pan et al. from the Tongji University, China have published the Article: The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass, in the Journal: (JOURNAL)
- what: The study showed that the postoperative adverse outcomes were acceptable (5.71%) in patients who underwent emergent cardiovascular surgery; the pre-operative LVEF and amp;lt;35%, postoperative pneumonia, and the BPI on chest X-ray were independent risk factors for postoperative adverse outcomes; the administration of sivelestat might improve postoperative outcomes in patients with ALI after emergent cardiovascular surgery. Study limitation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.